Eli Lilly & Co. (LLY)
1041.29
+2.89
(+0.28%)
USD |
NYSE |
Jan 20, 16:00
1040.05
-1.24
(-0.12%)
Pre-Market: 20:00
Eli Lilly Research and Development Expense (TTM): 12.56B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Adverum Biotechnologies, Inc. | 128.88M |
| Viking Therapeutics, Inc. | 222.48M |
| Moderna, Inc. | 3.271B |